National and Kapodistrian University of Athens
Ανοσοβιολογική μελέτη της χρήσης πεπτιδίων και μονοκλωνικών αντισωμάτων στην επιλεκτική χημειοθεραπεία του καρκίνου
Abstract
dc:descriptionIn the present thesis, a 10-amino acid sequence, namely BagP, located within BAG-1 protein and which is rich in arginine and lysine residues was tested for its ability to act as a macromolecular carrier translocating cellular membranes. BagP was found to be a successful cell penetrating peptide (CPP), transferring high molecular weight cargo intracellularly in a vast range of cell types, albeit variably, with normal cells demonstrating a less permeable target for BagP, in contrast to the universal uptake of other peptides observed. The penetrating phenomenon of BagP was found to be both time- and concentration-dependent. In addition, the translocating ability of the peptide was found to be energy-reliant. Furthermore, the overall positive charge of BagP, as well as its initial interaction with heparin sulfate proteoglycans of the cellular membrane were found to be important parameters for its mechanism of translocation. The N-terminal of Bag-1 is known to play a key part in the protein’s anti-apoptotic role. Since BagP originates from the N-terminal of Bag-1, the peptide was tested for its ability to act antagonistically to several pathways that this terminal is known to be involved in. Hence, the antagonistic action of BagP in cells expressing Bag-1 would cause increased apoptosis. It was found that BagP at a concentration of 0,5 mM was able to induce increased apoptosis of the T cell lymphoma cell lines ALC (murine) and KARPAS-299 (human). The rest of the cell lines tested remained unaffected, whereas smaller BagP concentrations had no biological effect in all the cell lines tested. It is well documented that resting Natural Killer (NK) cells express the common β and γ subunits of interleukin (IL)-2 and IL-15 receptors, and that NK proliferation increases in the presence of IL-2 or IL-15, whilst IL-2 increases Bag-1 concentration. Therefore, it was tested whether incubation of resting NK cells with BagP would antagonize the increase of Bag-1 concentration due to the presence of IL-15. Similarly, only 0,5 mM of Bag-1 concentration was found to increase the percentage of apoptotic cells. Moreover, since Bag-1 inhibits the action of glucocorticoid receptor, if BagP would act as a Bag-1 antagonist, it would interrupt such an inhibition, leading to cellular death. Indeed, BagP at 0,5 mM, was found to lead to significant reduction of NK cell proliferation. Finally, we examined the ability of the BagP peptide to transfer intracellularly biologically active macromolecules. Initially, BagP was conjugated to an antisense oligonucleotide sequence (antimyc-aug) that is known to inhibit the expression of c-myc gene. The conjugate was found to be intracellularly transferred and to cause a reduction of the proliferation rate, without affecting cellular viability, while it was found to reduce the concentration of c-MYC protein. In addition, BagP was complexed to monoclonal antibody Trastuzumab (Herceptin). The purpose of this experimental approach was to check if the intracellular localization of the antibody in cells expressing the antibody’s targeting protein, HER2/neu, would prevent its expression on the cell membrane, thus reducing the cells’ ability to proliferate. The outcome of the experimental procedures was neither clear nor conclusive and further investigation is required.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2010
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Νιάρχος, Δημήτριος
- Niarchos, Dimitrios
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/18704